Skip to content
TrialScanner

NCT06058039

Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

Phase 3CompletedNMRALead

Registry record

Lead sponsor
Neumora Therapeutics, Inc.
Conditions
Major Depressive Disorder
Primary completion
May 4, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06058039 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.